0.082
0.00 (0.00%)
| Penutupan Terdahulu | 0.082 |
| Buka | 0.082 |
| Jumlah Dagangan | 16,504 |
| Purata Dagangan (3B) | 19,971 |
| Modal Pasaran | 2,677,021 |
| Harga / Jualan (P/S) | 0.330 |
| Harga / Buku (P/B) | 3.84 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Aug 2024 - 2 Sep 2024 |
| Margin Keuntungan | -106.79% |
| Margin Operasi (TTM) | -56.43% |
| EPS Cair (TTM) | -0.180 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 137.00% |
| Nisbah Semasa (MRQ) | 0.090 |
| Aliran Tunai Operasi (OCF TTM) | -2.45 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.33 M |
| Pulangan Atas Aset (ROA TTM) | -109.93% |
| Pulangan Atas Ekuiti (ROE TTM) | -2,804.87% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (AU) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | IMAGIONBIO FPO [IBX] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -0.50 |
|
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.43% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |